Boston Scientific launches DBS system in Europe after approval – Zacks.com
Boston Scientific Corporation (BSX – Free Report) announced the receipt of the CE mark and the limited market launch of its fourth generation Vercise Genus (“DBS”) deep brain stimulation system in Europe. The system is indicated for the treatment of symptoms of Parkinson’s disease (“PD”) and dystonia because it delivers precisely targeted electrical stimulation to […]
The post Boston Scientific…